Developing Breakthrough Therapy to Reverse Disability After Stroke
Developing
Breakthrough
Therapy
to
Reverse
Disability
After
Stroke
Novel,
AI-powered,
tailored
electromagnetic
stimulation
aimed
to
help
you
achieve
freedom
from
disability
following
a
stroke
from
the
comfort
of
your
home
Proud to collaborate with esteemed research and medical institutions
Proud
to
collaborate
with
esteemed
research
and
medical
institutions


* Feigin, Valery L., et al. "World Stroke Organization (WSO): global stroke fact sheet 2022." International Journal of Stroke 17.1 (2022): 18-29
** Lee, Kyoung Bo, et al. "Six-month functional recovery of stroke patients: a multi-time-point study." International journal of rehabilitation research 38.2 (2015): 173-180
‘Freedom From Disability’ is the ultimate goal for stroke survivors
‘Freedom
From
Disability’
is
the
ultimate
goal
for
stroke
survivors

Independence at Home

Returning to Work

Family Time

Hobbies
Our investigational therapy has already demonstrated promising results in regaining 'freedom from disability' in well-designed studies
Our
investigational
therapy
has
already
demonstrated
promising
results
in
regaining
'freedom
from
disability'
in
well-designed
studies

Granted
FDA
Breakthrough
Device
Designation
Investigational
Device
designed
for
safe
use
wherever
you
are,
in
the
clinic
or
at
home.
Brain Relearning. Reimagined with AI.
Brain
Relearning.
Reimagined
with
AI.
Reversing
stroke
disability
requires
the
brain's
neural
networks
to
relearn
lost
functions.

Learn more about the patient experience from our first participant in our EMAGINE clinical trial
Learn
more
about
the
patient
experience
from
our
first
participant
in
our
EMAGINE
clinical
trial
Awards & Recognition
Awards
&
Recognition
Quest for Brain Health
Quest
for
Brain
Health
As we age, brain health emerges as the greatest challenge for each of us.
BRAIN.Q symbolizes our devotion to navigating this quest with humility and persistence, with the goal of enhancing brain health.
As the first steps in this quest, BRAIN.Q has successfully conducted several clinical and preclinical studies in a variety of neurological conditions with the goal of improving patient outcomes.
From the News
From
the
News